BioWorld - Saturday, March 14, 2026

BioWorld Science

June 23, 2022

View Archived Issues

EGFRvIII T-cell bispecific antibody activity in glioblastoma models

Read More

Biodistribution and efficacy of [177Lu]rhPSMA-10.1 compared to [177Lu]PSMA-I&T in prostate cancer

Read More

New P2X purinoceptor 3 antagonists discovered at Chiesi

Read More

Roche synthesizes new HBV HBsAg and HBeAg inhibitors

Read More

Katholieke Universiteit Leuven describes new TRPM3 antagonists

Read More

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent TLR7/8/9 antagonists

Read More

Pfizer identifies compounds targeting transthyretin

Read More

A novel Smad4-mutated mouse model of Myhre Syndrome

Read More

Novel virus-like vaccine candidate against HERV-K shows promise in preclinical breast cancer

Read More

FGFR and PDGFR as targets for CNS tumors with BCOR alterations

Read More

Data in mice support potential of ATL-1102 for limb girdle muscular dystrophy R2

Read More

VPAC receptor-specific Cu-67-TP-3805 shows theranostic potential for prostate cancer

Read More

CAIX-targeting radiopeptides show promise in preclinical models of cancer

Read More

Mindset Pharma collaborates with CAMH on preclinical evaluation of MSP-1014

Read More

Apellis and Affilogic expand R&D collaboration to include Nanofitins targeting TfR

Read More

Inhibitor harms leukemic stem cells while boosting normal ones

Read More